Open AccessVascular normalization therapy with targeted localized vessel bevacizumab infusion in hepatocellular carcinoma after transarterial chemoembolization failure
Author(s) -
Haixiao Zhang,
Gengfei Cao,
Weixin Ren,
Gu Junpeng,
Weizheng Ji,
Diwen Zhu,
Yingjun Bao,
Asihaer Hasimu
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-2123
Subject(s) - medicine , hepatocellular carcinoma , bevacizumab , vascularity , oncology , radiology , chemotherapy
Hepatocellular carcinoma (HCC) is a highly vascularized tumor in which abnormal blood vessels contribute to poor treatment efficacy and prognosis. In this study, we assessed the efficacy, safety, and potential ability of bevacizumab to normalize tumor vascularity in patients with advanced HCC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom